查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
血糖监测市场：按类型、按组成部分、按地区 - 规模、份额、展望、机会分析，2022-2028 年
市场调查报告书
商品编码
1181706

血糖监测市场：按类型、按组成部分、按地区 - 规模、份额、展望、机会分析，2022-2028 年

Blood Glucose Monitoring Market, By Type, By Component, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

定期监测血糖对于糖尿病管理至关重要。 这是糖尿病患者为控制 1 型或 2 型糖尿病所能做的最重要的事情。 血糖监测是使用血糖仪检测血液中的葡萄糖水平。 自我监测血糖仪 (SMBG) 是一种手持设备，供患者在家中检查血糖水平。 另一方面，连续血糖仪 (CGM) 可以通过更少的手指测试帮助管理 1 型或 2 型糖尿病。 因此，随着糖尿病患者数量的增加，对血糖监测的需求也在迅速增加。

市场动态

糖尿病患病率或发病率上升、公众对糖尿病管理的认识提高、血糖监测设备的采用率增加、研发增加、市场上产品数量增加、有利的政府举措是预计推动增长的主要因素全球血糖监测市场。

例如，2021 年 3 月，罗氏宣布推出新的联网血糖监测系统 ACCU-CHEK Instant System，该系统支持并使罗氏的综合个性化糖尿病管理 (iPDM) 方法得以增加。 该系统通过蓝牙连接连接到 mySugr 应用程序，并可以将血糖读数无线传输到 mySugr 应用程序。 该应用程序提供糖尿病管理功能，例如 mySugr 胰岛素计算器，以及快速了解用户的糖尿病数据。

此外，2019 年 1 月，美国食品和药物管理局 (FDA) 批准了一种用于 1 型和 2 型糖尿病患者的植入式连续血糖监测 (CGM) 设备。 该设备称为 Eversense 连续血糖监测系统，可提供长达三个月的监测，并被批准用于 18 岁及以上的人群。

这项研究的主要特点

  • 本报告对全球血糖监测市场进行了深入分析，提供了以 2021 年为基准年的预测期（2022-2028 年）的市场规模和復合年增长率 (CAGR %) 增长情况。
  • 解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
  • 它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
  • 它根据以下参数介绍了全球血糖监测市场的主要参与者，包括公司亮点、产品组合、主要亮点、财务业绩和战略。
  • 本研究涵盖的主要公司包括 Sensonics、Acon Laboratories Inc.、Bionime Corporation、AgaMatrix Inc.、Ascensia Diabetes Care、ARKRAY Inc.、Medisana AG、Medtronic PLC、DexCom Inc.、LifeScan Inc.、Roche Diagnostics 、Abbott Diabetes Care、Trivida Functional Medicine 和 Rossmax International Ltd. 等。
  • 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。我猜。
  • 《全球血糖监测市场》报告针对行业内的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以通过用于分析全球血糖监测市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第二章市场展望

  • 报告内容
    • 市场定义和范围
  • 执行摘要
    • 市场概况：按类型分类
    • 市场概况：按组件分类
    • 市场概况：按地区
  • 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

  • 市场动态
    • 全球糖尿病患病率和发病率增加
    • 血糖仪成本高，报销率低
    • 血糖仪普及率提高
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布和批准
  • 害虫分析
  • 对 PORTER 的分析
  • 合併/收购场景

第 4 章全球血糖监测市场 - 冠状病毒 (COVID-19) 大流行的影响

  • COVID-19 的流行病学
  • 供应方和需求方分析
  • 经济影响

第 5 章全球血糖监测市场，按类型，2017-2028

  • 自我监测血糖仪
  • 连续血糖监测设备

第 6 章全球血糖监测市场的组成部分，2017-2028

  • 血糖仪设备
  • 试纸
  • 柳叶刀
  • 传感器
  • 耐用性

第 7 章全球血糖监测市场，按地区划分，2017-2028

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
  • 世界其他地方

第八章竞争格局

  • Senseonics
  • Medisana AG
  • Acon Laboratories Inc.
  • Bionime Corporation
  • AgaMatrix Inc.
  • Ascensia Diabetes Care
  • ARKRAY Inc.
  • Medtronic PLC
  • DexCom Inc.
  • LifeScan Inc.
  • Roche Diagnostics
  • Abbott Diabetes Care
  • Trivida Functional Medicine
  • Rossmax International Ltd.

第 9 章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5382

Regular blood glucose monitoring is essential for diabetes management. It is the most important thing people with diabetes can do to manage Type 1 or Type 2 diabetes. Blood glucose monitoring is the use of a glucose meter to test the concentration of glucose in the blood. Self-monitoring of blood glucose (SMBG) devices are handheld devices used by patients at home to check their blood glucose levels. While, continuous glucose monitoring (CGM) devices help people manage Type 1 or Type 2 diabetes with fewer fingerstick tests. Thus, with the increase in prevalence of diabetes, the demand for blood glucose monitoring is also increasing rapidly.

Market Dynamics:

Rise in prevalence or incidence of diabetes, increase in awareness among people about diabetes management, increase in adoption of blood glucose monitoring devices, increase in research and development, increase in number of product launches, and favorable government initiatives are major factors expected to drive growth of the global blood glucose monitoring market.

For instance, in March 2021, Roche announced the launch of the new Accu-Chek Instant system, a new connected blood glucose monitoring system, which supports and enables Roche's approach of integrated Personalized Diabetes Management (iPDM). The system features Bluetooth enabled connectivity to the mySugr app, allowing wireless transfer of blood glucose results to the mySugr app. The app offers users quick insights to their diabetes data in addition to diabetes management features like the mySugr insulin calculator.

Moreover, in January 2019, the U.S. Food and Drug Administration (FDA) approved implantable continuous glucose monitoring (CGM) device for individuals with type 1 and type 2 diabetes. The device, called the Eversense Continuous Glucose Monitoring System, provides monitoring for up to three months, and it's approved for people age 18 and older.

Key features of the study:

  • This report provides in-depth analysis of the global blood glucose monitoring market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global blood glucose monitoring market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Senseonics, Acon Laboratories Inc., Bionime Corporation, AgaMatrix Inc., Ascensia Diabetes Care, ARKRAY Inc., Medisana AG, Medtronic PLC, DexCom Inc., LifeScan Inc., Roche Diagnostics, Abbott Diabetes Care, Trivida Functional Medicine, and Rossmax International Ltd., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global blood glucose monitoring market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood glucose monitoring market.

Detailed Segmentation:

  • Global Blood Glucose Monitoring Market, By Type:
    • Self-monitoring blood glucose devices
    • Continuous glucose monitoring devices
  • Global Blood Glucose Monitoring Market, By Component:
    • Glucometer devices
    • Test strips
    • Lancets
    • Sensors
    • Durables
  • Global Blood Glucose Monitoring Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Company Profiles:
    • Senseonics
    • Medisana AG
    • Acon Laboratories Inc.
    • Bionime Corporation
    • AgaMatrix Inc.
    • Ascensia Diabetes Care
    • ARKRAY Inc.
    • Medtronic PLC
    • DexCom Inc.
    • LifeScan Inc.
    • Roche Diagnostics
    • Abbott Diabetes Care
    • Trivida Functional Medicine
    • Rossmax International Ltd.

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Component
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increase in prevalence/incidence of diabetes across the globe
    • High cost and poor reimbursement of blood glucose monitoring devices
    • Increase in adoption of blood glucose monitoring devices
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Blood Glucose Monitoring Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Blood Glucose Monitoring Market, By Type, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Self-monitoring blood glucose devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Continuous glucose monitoring devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Blood Glucose Monitoring Market, By Component, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Glucometer devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Test strips
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Lancets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Sensors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Durables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Blood Glucose Monitoring Market, By Geography, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

8. Competitive Landscape

  • Senseonics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medisana AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Acon Laboratories Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bionime Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AgaMatrix Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ascensia Diabetes Care
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ARKRAY Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DexCom Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • LifeScan Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Roche Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Diabetes Care
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Trivida Functional Medicine
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Rossmax International Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us